| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.49B | -14.3% |
| Cost of Revenue | $453.8M | -17.5% |
| Gross Profit | $1.03B | -12.7% |
| R&D Expense | $10.8M | -16.9% |
| SG&A Expense | $432.1M | -9.8% |
| Operating Income | $65.8M | +143.4% |
| Pre-tax Income | $196.2M | +212.1% |
| Income Tax | $36.0M | +226.5% |
| Net Income | $160.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.6M | +27.7% |
| Short-term Investments | $1.2M | -89.1% |
| Accounts Receivable | $39.5M | -22.1% |
| Inventory | $178.6M | -6.1% |
| Current Assets | $547.7M | +1.7% |
| Total Assets | $1.41B | -4.3% |
| Current Liabilities | $263.7M | -11.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $80.3M | -28.2% |
| Capital Expenditures | $34.3M | -17.6% |
| Investing Cash Flow | $170.7M | +549.6% |
| Financing Cash Flow | -$202.4M | -52.0% |
| Free Cash Flow | $46.0M | -34.4% |
| +209.3% |
| EPS (Basic) | $3.25 | +210.2% |
| EPS (Diluted) | $3.18 | +207.8% |
| Long-term Debt |
| $204.2M |
| -43.8% |
| Total Liabilities | $600.1M | -26.6% |
| Stockholders' Equity | $805.2M | +23.6% |